Items where Author is "Gambichler, T."

Article

Kreuter, A. and Rasokat, H. and Klouche, Mariam and Esser, S. and Bader, A. and Gambichler, T. and Altmeyer, P. and Brockmeyer, N. (2005) Liposomal pegylated doxorubicin versus low-dose recombinant interferon alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers. CANCER INVESTIGATION, 23 (8). pp. 653-659. ISSN 0735-7907, 1532-4192

Conference or Workshop Item

Franklin, C. and Mohr, P. and Meier, F. and Weichenthal, M. and Grimmel-Mann, I. and Gutzmer, R. and Utikal, J. S. and Terheyden, P. and Herbst, R. and Haferkamp, Sebastian and Pföhler, C. and Leiter-Stöppke, U. and Ziller, F. and Meiß, F. and Ulrich, J. and Kreuter, A. and Gebhardt, C. and Welzel, J. and Schilling, B. and Kaatz, M. and Scharfetter-Kochanek, K. and Dippel, E. and Nashan, D. and Sachse, M. M. and Weishaupt, C. and Löffler, H. and Gambichler, T. and Loquai, C. and Heinzerling, L. and Grabbe, S. and Debus, D. and Schley, G. and Weyandt, G. and Trommer, M. and Lodde, G. and Placke, J. M. and Zimmer, L. and Livingstone, E. and Horn, S. and Schadendorf, D. and Ugurel, S. (2022) FV20 Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG. In: 32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover.

Franklin, C. and Mohr, P. and Bluhm, L. and Grimmelmann, I. and Gutzmer, R. and Meier, F. and Garzarolli, M. and Weichenthal, M. and Herbst, R. and Pföhler, C. and Terheyden, P. and Utikal, J. S. and Ulrich, J. and Debus, D. and Haferkamp, Sebastian and Kaatz, M. and Forschner, A. and Leiter-Stöppke, U. and Nashan, D. and Kreuter, A. and Sachse, M. M. and Welzel, J. and Heinzerling, L. and Meiß, F. and Weishaupt, C. and Gambichler, T. and Weyandt, G. and Dippel, E. and Schatton, K. and Celik, E. and Trommer, M. and Helfrich, I. and Rösch, A. and Zimmer, L. and Livingstone, E. and Schaden-Dorf, D. and Horn, S. and Ugurel, S. (2022) eP003 Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. In: 32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover.

Spassova, I. and Ugurel, S. and Zimmer, L. and Schadendorf, D. and Terheyden, P. and Andtback, H. B. and Villabona, L. and Leiter-Stoeppke, U. and Eigentler, T. and Loquai, C. and Hassel, J. C. and Gambichler, T. and Haferkamp, S. and Mohr, P. and Pfoehler, C. and Heinzerling, L. and Horny, K. and Habermann, D. and Hoffmann, D. and Becker, J. C. (2020) Immune-Checkpoint-Blockade for Merkel Cell Carcinoma: Clinical and molecular Biomarker-Analysis. In: 30. Deutscher Hautkrebskongress (ADO‐Jahrestagung), 9. bis 12. September 2020, Virtuell.

Other

Leiter-Stoeppke, U. and Loquai, C. and Meier, F. and Rafei-Shamsabadi, D. and Hassel, J. and Glutsch, V. and Sirokay, J. and Schlecht, N. and Ruebben, A. and Gutzmer, R. and Kaehler, K. and Gambichler, T. and Schatton, K. and Pfoehler, C. and Franklin, C. and Terheyden, P. and Haferkamp, S. and Mohr, P. and Heinzerling, L. and Meiwes, A. and Keim, U. and Becker, J. C. and Bischof, L. and Livingstone, E. and Schadendorf, D. and Ugurel, S. (2019) Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO. WILEY, HOBOKEN.